235 related articles for article (PubMed ID: 16302266)
1. Allelotyping analysis at chromosome 13q of high-grade prostatic intraepithelial neoplasia and clinically insignificant and significant prostate cancers.
Lu W; Takahashi H; Furusato M; Maekawa S; Nakano M; Meng C; Kikuchi Y; Sudo A; Hano H
Prostate; 2006 Mar; 66(4):405-12. PubMed ID: 16302266
[TBL] [Abstract][Full Text] [Related]
2. Allelotyping analysis at chromosome arm 8p of high-grade prostatic intraepithelial neoplasia and incidental, latent, and clinical prostate cancers.
Lu W; Takahashi H; Furusato B; Maekawa S; Ikegami M; Sudo A; Egawa S; Hano H
Genes Chromosomes Cancer; 2006 May; 45(5):509-15. PubMed ID: 16470536
[TBL] [Abstract][Full Text] [Related]
3. Deletion at chromosome arms 6q16-22 and 10q22.3-23.1 associated with initiation of prostate cancer.
Lu T; Hano H
Prostate Cancer Prostatic Dis; 2008; 11(4):357-61. PubMed ID: 18227855
[TBL] [Abstract][Full Text] [Related]
4. [Frequent allelic losses in tumor-associated stromal cells and tumor epitelium of prostate cancer].
Kekeeva TV; Popova OP; Shegaĭ PV; Zavalishina LE; Andreeva IuIu; Zaletaev DV; Nemtsova MV
Mol Biol (Mosk); 2008; 42(1):96-101. PubMed ID: 18389625
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of loss of heterozygosity on chromosome 8 in human prostate carcinoma and high grade prostatic intraepithelial neoplasia].
Wang Z; Lai FM
Zhonghua Nan Ke Xue; 2004 Jan; 10(1):26-8, 31. PubMed ID: 14979203
[TBL] [Abstract][Full Text] [Related]
6. Three distinct regions of allelic loss at 13q14, 13q21-22, and 13q33 in prostate cancer.
Hyytinen ER; Frierson HF; Boyd JC; Chung LW; Dong JT
Genes Chromosomes Cancer; 1999 Jun; 25(2):108-14. PubMed ID: 10337994
[TBL] [Abstract][Full Text] [Related]
7. Allelic loss of 8p sequences in prostatic intraepithelial neoplasia and carcinoma.
Häggman MJ; Wojno KJ; Pearsall CP; Macoska JA
Urology; 1997 Oct; 50(4):643-7. PubMed ID: 9338751
[TBL] [Abstract][Full Text] [Related]
8. Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer.
Fromont G; Valeri A; Cher M; Pontes JE; Vallancien G; Validire P; Latil A; Cussenot O
Prostate; 2005 Dec; 65(4):341-6. PubMed ID: 16015610
[TBL] [Abstract][Full Text] [Related]
9. Identification of a I-cM region of common deletion on 13q14 associated with human prostate cancer.
Ueda T; Emi M; Suzuki H; Komiya A; Akakura K; Ichikawa T; Watanabe M; Shiraishi T; Masai M; Igarashi T; Ito H
Genes Chromosomes Cancer; 1999 Mar; 24(3):183-90. PubMed ID: 10451697
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic heterogeneity of high-grade prostatic intraepithelial neoplasia: clues for clonal progression in prostate carcinogenesis.
Henrique R; Jerónimo C; Teixeira MR; Hoque MO; Carvalho AL; Pais I; Ribeiro FR; Oliveira J; Lopes C; Sidransky D
Mol Cancer Res; 2006 Jan; 4(1):1-8. PubMed ID: 16446401
[TBL] [Abstract][Full Text] [Related]
11. Chromosome 16 allelic loss analysis of a large set of microdissected prostate carcinomas.
Strup SE; Pozzatti RO; Florence CD; Emmert-Buck MR; Duray PH; Liotta LA; Bostwick DG; Linehan WM; Vocke CD
J Urol; 1999 Aug; 162(2):590-4. PubMed ID: 10411092
[TBL] [Abstract][Full Text] [Related]
12. Distinct regions of allelic loss on 13q in prostate cancer.
Cooney KA; Wetzel JC; Merajver SD; Macoska JA; Singleton TP; Wojno KJ
Cancer Res; 1996 Mar; 56(5):1142-5. PubMed ID: 8640774
[TBL] [Abstract][Full Text] [Related]
13. High grade prostatic intraepithelial neoplasia does not display loss of heterozygosity at the mutation locus in BRCA2 mutation carriers with aggressive prostate cancer.
Willems-Jones A; Kavanagh L; Clouston D; Bolton D; ; Fox S; Thorne H
BJU Int; 2012 Dec; 110(11 Pt C):E1181-6. PubMed ID: 23035815
[TBL] [Abstract][Full Text] [Related]
14. High-grade prostate intraepithelial neoplasia shares cytogenetic alterations with invasive prostate cancer.
Alcaraz A; Barranco MA; Corral JM; Ribal MJ; Carrió A; Mallofré C; Llopis J; Cetina A; Alvarez-Vijande R
Prostate; 2001 Apr; 47(1):29-35. PubMed ID: 11304727
[TBL] [Abstract][Full Text] [Related]
15. HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected androgen-dependent and androgen-independent cancer.
Montironi R; Mazzucchelli R; Barbisan F; Stramazzotti D; Santinelli A; Scarpelli M; Lòpez Beltran A
Hum Pathol; 2006 Sep; 37(9):1137-44. PubMed ID: 16938518
[TBL] [Abstract][Full Text] [Related]
16. Extensive analysis of the 13q14 region in human prostate tumors: DNA analysis and quantitative expression of genes lying in the interval of deletion.
Latil A; Chêne L; Mangin P; Fournier G; Berthon P; Cussenot O
Prostate; 2003 Sep; 57(1):39-50. PubMed ID: 12886522
[TBL] [Abstract][Full Text] [Related]
17. Allelic loss on chromosome 13q in human prostate carcinoma.
Melamed J; Einhorn JM; Ittmann MM
Clin Cancer Res; 1997 Oct; 3(10):1867-72. PubMed ID: 9815575
[TBL] [Abstract][Full Text] [Related]
18. Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3.
Yin Z; Spitz MR; Babaian RJ; Strom SS; Troncoso P; Kagan J
Oncogene; 1999 Dec; 18(52):7576-83. PubMed ID: 10602517
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein-D: a novel cellular marker for HGPIN and prostate cancer.
Hall RE; Horsfall DJ; Stahl J; Vivekanandan S; Ricciardelli C; Stapleton AM; Scardino PT; Neufing P; Tilley WD
Prostate; 2004 Feb; 58(2):103-8. PubMed ID: 14716735
[TBL] [Abstract][Full Text] [Related]
20. Integrative analysis of genomic aberrations associated with prostate cancer progression.
Kim JH; Dhanasekaran SM; Mehra R; Tomlins SA; Gu W; Yu J; Kumar-Sinha C; Cao X; Dash A; Wang L; Ghosh D; Shedden K; Montie JE; Rubin MA; Pienta KJ; Shah RB; Chinnaiyan AM
Cancer Res; 2007 Sep; 67(17):8229-39. PubMed ID: 17804737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
